1641640 - Nabriva Therapeutics Plc - SEC Form 4 Insider Trading Screener
35 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| S | 6 | +4 | +1 | -11 | +0 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-07-31 | NBRV | Talbot George Harrison | Dir | P - Purchase | $2.75 | +14,500 | 47,640 | +44% | +$39,875 | ||||||
| D | 2018-07-31 | NBRV | Burgess Daniel D | Dir | P - Purchase | $2.75 | +36,000 | 36,000 | New | +$99,000 | |||||
2018-06-23 | NBRV | Gelone Steven P. | Chief Scientific Officer | P - Purchase | $3.82 | +10,000 | 22,740 | +78% | +$38,200 | ||||||
2018-06-22 | NBRV | Schranz Jennifer | Chief Medical Officer | P - Purchase | $3.73 | +5,500 | 5,500 | New | +$20,515 | ||||||
2018-06-22 | NBRV | Broom Colin Md | CEO, Dir | P - Purchase | $3.72 | +5,000 | 175,000 | +3% | +$18,600 | ||||||
2018-05-23 | NBRV | Lavino Francesco Maria | Chief Commercial Officer | P - Purchase | $4.60 | +2,160 | 3,719 | +139% | +$9,936 | ||||||
2018-05-23 | NBRV | Sender Gary | CFO | P - Purchase | $4.57 | +2,000 | 6,200 | +48% | +$9,140 | ||||||
2018-05-23 | NBRV | Webster Stephen W | Dir | P - Purchase | $4.59 | +8,000 | 8,000 | New | +$36,720 | ||||||
2018-05-23 | NBRV | Broom Colin Md | CEO, Dir | P - Purchase | $4.60 | +10,000 | 170,000 | +6% | +$46,000 | ||||||
2018-05-23 | NBRV | Crotty Robert | GC, Secretary | P - Purchase | $4.48 | +10,000 | 10,000 | New | +$44,800 | ||||||
2017-11-29 | NBRV | Lavino Francesco Maria | Chief Commercial Officer | P - Purchase | $6.29 | +1,569 | 1,569 | New | +$9,869 | ||||||
| D | 2017-09-27 | NBRV | Talbot George Harrison | Dir | M - OptEx | $0.00 | +1,350 | 33,140 | +4% | +$0 | |||||
2017-09-22 | NBRV | Sender Gary | CFO | P - Purchase | $8.21 | +2,000 | 4,200 | +91% | +$16,420 | ||||||
2017-09-22 | NBRV | Broom Colin Md | CEO | P - Purchase | $8.35 | +2,588 | 160,000 | +2% | +$21,610 | ||||||
2017-09-18 | NBRV | Vivo Capital Viii, LLC | 10% | P - Purchase | $9.46 | +52,631 | 4,074,190 | +1% | +$497,889 | ||||||
| M | 2017-09-12 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $8.56 | -36,608 | 2,334,128 | -2% | -$313,415 | |||||
2017-08-31 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $9.50 | -639 | 2,370,735 | 0% | -$6,071 | ||||||
| M | 2017-08-07 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $10.50 | -19,803 | 2,371,374 | -1% | -$207,932 | |||||
2017-07-28 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $10.51 | -6,585 | 2,391,177 | 0% | -$69,195 | ||||||
2017-07-24 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $10.50 | -160 | 2,397,762 | 0% | -$1,680 | ||||||
| M | 2017-07-19 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $10.50 | -44,231 | 2,397,922 | -2% | -$464,426 | |||||
| M | 2017-06-30 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $10.94 | -13,127 | 2,571,877 | -1% | -$143,670 | |||||
| M | 2017-06-27 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $10.96 | -8,558 | 2,585,004 | 0% | -$93,804 | |||||
| M | 2017-06-15 | NBRV | Talbot George Harrison | Dir | S - Sale | $93.18 | -170 | 3,179 | -5% | -$15,840 | |||||
2017-06-01 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $11.27 | -400 | 2,593,562 | 0% | -$4,508 | ||||||
2017-05-30 | NBRV | Talbot George Harrison | Dir | S - Sale | $101.26 | -210 | 3,349 | -6% | -$21,265 | ||||||
| M | 2017-05-23 | NBRV | Talbot George Harrison | Dir | S - Sale | $100.56 | -325 | 3,559 | -8% | -$32,684 | |||||
| D | 2017-02-16 | NBRV | Talbot George Harrison | Dir | M - OptEx | $0.00 | +1,235 | 3,884 | +47% | +$0 | |||||
| DM | 2017-05-15 | NBRV | Talbot George Harrison | Dir | S - Sale+OE | $102.44 | -200 | 3,884 | -5% | -$20,488 | |||||
| M | 2017-04-26 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $11.02 | -15,939 | 2,593,962 | -1% | -$175,712 | -1 | -4 | |||
2017-04-21 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $11.04 | -2,622 | 2,609,901 | 0% | -$28,937 | +3 | +1 | ||||
| M | 2017-04-18 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $11.11 | -23,932 | 2,612,523 | -1% | -$265,889 | +2 | +2 | |||
| M | 2017-04-11 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $11.24 | -32,831 | 2,636,455 | -1% | -$368,919 | +3 | -3 | -12 | ||
| AM | 2017-04-06 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $10.96 | -90,594 | 2,669,286 | -3% | -$992,542 | +7 | +3 | -10 | ||
| M | 2017-04-06 | NBRV | Hbm Healthcare Investments (Cayman) Ltd. | 10% | S - Sale | $10.96 | -90,594 | 185,394 | -33% | -$992,542 | +7 | +6 | -10 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |